The Pharmaceuticals sector of North America region, witnessed 25 Equity Offering deals in July 2022, for an aggregate deal value of $1,243.7 million. This represents a decrease of 19.7% in terms of value and a decrease of 25.0% in terms of volume, year over year.
A total of 306 Equity Offering deals were recorded over the last twelve months (LTM) for an aggregate deal value of $15,008.1 million. In the LTM period, November 2021, turned out to be the most prolific in terms of deal size, with a total deal value of $109.3 million and a deal volume of 3 during that month. On the other hand, the month of October 2021, was the most prolific in terms of deal volume, recording a total of 1 deals with a total deal value of $851,606.6 million during that month.
On an average, over the LTM period, 25 deals were done with an average deal size of $1,250.7 million.
United States of America
China
United States of America
United States of America
United States of America
United States of America
United States of America
United Kingdom
Switzerland
France
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer